|1.||Cho, Sung Ig: 4 articles (11/2010 - 04/2007)|
|2.||Gwag, Byoung Joo: 4 articles (11/2010 - 04/2007)|
|3.||Chung, Jun-Mo: 3 articles (02/2014 - 06/2007)|
|4.||Lim, Hyang Ran: 3 articles (01/2010 - 04/2007)|
|5.||Noh, Jai Sung: 2 articles (01/2010 - 04/2007)|
|6.||Kim, Kee-Won: 2 articles (06/2007 - 04/2007)|
|7.||Lee, Young Ae: 2 articles (06/2007 - 04/2007)|
|8.||Noh, Jihyun: 1 article (02/2014)|
|9.||Koh, Young-Hyun: 1 article (02/2014)|
|10.||Park, Ui Jin: 1 article (11/2010)|
|1.||Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
|3.||Spinal Cord Injuries (Spinal Cord Injury)
01/01/2010 - "The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury."
01/01/2010 - "The goal of the present study was to examine the neuroprotective and functional significance of targeting both N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity and oxidative stress using a dual-acting compound, Neu2000, in rat model of moderate spinal cord injury (SCI). "
|4.||Brain Injuries (Brain Injury)
06/01/2007 - "Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine."
02/01/2014 - "Neu2000 (NEU; 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid), a recently developed derivative of acetylsalicylic acid and sulfasalazine, potently protects against neuronal cell death following ischemic brain injury by antagonizing NMDA receptor-mediated neuronal toxicity and oxidative stress. "
|5.||Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
|4.||Aspirin (Acetylsalicylic Acid)
|5.||Benzoic Acid (Ucephan)